Roivant Sciences Ltd
ROIV · NASDAQ
Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch "Vants" - nimble and focused biopharmaceutical and health technology companies
Market Data
Price
$36.30
-0.54 (-1.47%)
Market Cap$26.21B
P/E Ratio—
EPS$—
52W High$37.97
52W Low$11.54
Beta1.11
Data from Finnhub · Updated Aug 23, 2026